Валерианова З., Димитрова Н., Вуков М., Атанасов Т. (ред.) Заболеваемост от рак в България, 2013. Български национален раков регистър, София 2015.
Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region.Mehanna H, Beech T, Nicholson T, El-Hariry I, McConkey C, Paleri V, Roberts SHead Neck. 2013 May; 35(5):747-55.
Global cancer statistics, 2002. Parkin DM, Bray F, Ferlay J, Pisani P CA Cancer J Clin. 2005 Mar-Apr; 55(2):74-108. [PubMed] [Ref list]
Kim SY, Roh JL, Yeo NK, Kim JS, Lee JH, Choi SH, Nam SY. Combined 18F-fluorodeoxyglucose-positron emission tomography and computed tomography as a primary screening method for detecting second primary cancers and distant metastases in patients with head and neck cancer. Ann Oncol. 2007; 18:1698–1703. [PubMed]
Kyzas PA, Evangelou E, Denaxa-Kyza D, Ioannidis JP. 18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis. J Natl Cancer Inst. 2008; 100:712–720. [PubMed]
Bundhit Tantiwongkosi, Fang Yu, Anand Kanard, and Frank R Miller. Role of 18F-FDG PET/CT in pre and post treatment evaluation in head and neck carcinoma. World J Radiol. 2014 May 28; 6(5): 177–191. Published online 2014 May 28. doi: 10.4329/wjr.v6.i5.177.
Еrcole Di Martino, MD; Bernd Nowak, MD; Hassan A. Hassan, MD; Ralf Hausmann; Gerhard Adam, MD; Udalrich Buell, MD;MartinWesthofen, MD. Diagnosis and Staging oh Head and Neck Cancer. A comparison of Modern Imaging Modalities (Positron Emission Tomography, Computer Tomography, Color-Code Duplex Sonography) With Panendoscopic and Histopathlogic Findings. ArhOtotlaryngol Head Neck surg/VOL 126, Dec 2000.
Dillon WP. Magnetic resonance imaging of head and neck tumors. CardiovascInterventRadiol. 1986;8 (5-6), 275-82.
W. Halfpenny, S F Hain,L Biassoni, M N Maisey, J A Sherman, and M McGurk. FDG–PET. A possible prognostic factor in head and neck cancer. Br J Cancer. 2002 Feb 12; 86(4): 512–516. doi: 10.1038/sj.bjc.6600114
Rusthoven KE, Koshy M, Paulino AC. The Role of Fluorodeoxyglucose Positron Emission Tomography in Cervical Lymph Node Metastases from an Unknown Primary Тumor. Cancer. 2004; 101:2641–2649.[PubMed]
Yoo J, S. Henderson, C. Walker- Dilks, Evidence-baced guideline recommendation on use of positron emission tomography imaging in the head and neck cancer. Clinical Oncology 2013; 25(4):e33-e66
Jorgen Jahansen, Simon Buus,Annika Loft et al.Prospective study of 18F-FDG PET/CT in detection and menagment of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13. Nead Neck. Journal of the sciences and specialtiest of the head and neck. 19 November 2017.https://doi.org/10.1002/hed.20734
Ng SH, Yen TC, Chang JT, et al, Prospective study of 18F fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpable negative neck. J ClinOncol 2006; 24(27):4371-4376.
Schoder H, Carlson DL, Kraus DH, et al. 18F-FDG PET/CT for detecting nodal metastases in patient with patients with oral cancer staged N0 by clinical examination and CT/MRI. J Nucl Med 2006; 47(5):755-762.
Wensing BM, Vogel WV, Marres HA, et al, FDG-PET in clinically negative neck in oral squamous cell carcinoma. Laryngoscope 2006;116(5):809-813.
Kovac AF, Dobert N, Gaa J, et al, Positron emission tomography in combination with sentinel node biopsy reduced the rate of elective neck dissection in the treatment of oral and oropharengeal carcinoma. J ClinOncol 2004; 22(19):3973-3980.
S.Y.Kim, J.-L.Roh, N.-K.Yeo, J.S.Kim, J.H.Lee, S,H.Choi&S.Y.Nam, Combined 18F-fluorodeoxyglucose-positron emission tomography and computed tomography as a primary screening method for detecting second primary cancers and distant metastases in patients with head and neck cancer.
Gupta T, Master Z, Kannan S, Agarwal JP, Ghsoh-Laskar S, Rangarajan V, Murthy V, Budrukkar A. Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2011; 38:2083–2095. [PubMed]
Adams S., Baum R.P., Stuckensen T., Bitter K., Hor G. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med. 1998; 25:1255–1260. [PubMed].
Schoder H, Yeung HW. Positron emission imaging of head andneck cancer, including thyroid carcinoma. SeminNucl Med.2004; 34:180-197.
M.G. Isles, C. McConkey, H.M. Mehanna. A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy. 5 June 2008 DOI: 10.1111/j.1749-4486.2008.01688.
